tirzepatide microdose side effects Micro-Dose Program | Weight Maintenance THE GLP-1 MICRODOSING PROGRAM

Semaglutide injection activates GLP-1 receptors in your brain and gut within hours of administration, triggering changes in hunger signals and blood sugar regulation

While not intended as a dedicated weight-loss therapy (for significant weight management, we recommend our full program), microdosing can support gradual, sustainable weight control as part of a longevity-focused regimen

We'll explore why individuals stop taking the drug, examine the physiological changes that occur when discontinuing it and offer insights on how to manage the transition safely

During this initial meeting, we'll listen to your story, understand your health goals, and conduct a comprehensive medical evaluation to determine if a GLP-1 program is the right fit for you

Animal experiments verified the inhibitory effect of Semaglutide on OSCC tumors in mice

According to clinical studies by the National Library of Medicine, those taking Semaglutide noticed "less appetite and food cravings, better control of eating and lower relative preference for fatty, energydense foods" after 12 weeks of treatment